A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Recruiting

Phase 1

BimekizumabA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Sponsor:

UCB Biopharma SRL

Code:

NCT07290036

Conditions

Psoriatic Arthritis

Axial Spondyloarthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bimekizumab regimen 1 iv

Bimekizumab regimen 2 iv

Bimekizumab regimen 3 sc

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-16. This information was provided to ClinicalTrials.gov by UCB Biopharma SRL on 2026-04-13.